Literature DB >> 23843626

The cytosolic chaperone α-crystallin B rescues folding and compartmentalization of misfolded multispan transmembrane proteins.

Massimo D'Agostino1, Valentina Lemma, Giancarlo Chesi, Mariano Stornaiuolo, Magda Cannata Serio, Chiara D'Ambrosio, Andrea Scaloni, Roman Polishchuk, Stefano Bonatti.   

Abstract

The α-crystallin B chain (CRYAB or HspB5) is a cytosolic chaperone belonging to the small heat shock protein family, which is known to help in the folding of cytosolic proteins. Here we show that CRYAB binds the mutant form of at least two multispan transmembrane proteins (TMPs), exerting an anti-aggregation activity. It rescues the folding of mutant Frizzled4, which is responsible for a rare autosomal dominant form of familial exudative vitreoretinopathy (Fz4-FEVR), and the mutant ATP7B Cu transporter (ATP7B-H1069Q) associated with a common form of Wilson's disease. In the case of Fz4-FEVR, CRYAB prevents the formation of inter-chain disulfide bridges between the lumenal ectodomains of the aggregated mutant chains, which enables correct folding and promotes appropriate compartmentalization on the plasma membrane. ATP7B-H1069Q, with help from CRYAB, folds into the proper conformation, moves to the Golgi complex, and responds to copper overload in the same manner as wild-type ATP7B. These findings strongly suggest that CRYAB plays a pivotal role, previously undetected, in the folding of multispan TMPs and, from the cytosol, is able to orchestrate folding events that take place in the lumen of the ER. Our results contribute to the explanation of the complex scenario behind multispan TMP folding; additionally, they serve to expose interesting avenues for novel therapeutic approaches.

Entities:  

Keywords:  ATP7B; Frizzled4; sHsp

Mesh:

Substances:

Year:  2013        PMID: 23843626     DOI: 10.1242/jcs.125443

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

Review 1.  Functions of crystallins in and out of lens: roles in elongated and post-mitotic cells.

Authors:  Christine Slingsby; Graeme J Wistow
Journal:  Prog Biophys Mol Biol       Date:  2014-02-28       Impact factor: 3.667

2.  Pharmacological folding chaperones act as allosteric ligands of Frizzled4.

Authors:  Serena F Generoso; Mariateresa Giustiniano; Giuseppe La Regina; Sara Bottone; Sara Passacantilli; Salvatore Di Maro; Hilde Cassese; Agostino Bruno; Massimo Mallardo; Monica Dentice; Romano Silvestri; Luciana Marinelli; Daniela Sarnataro; Stefano Bonatti; Ettore Novellino; Mariano Stornaiuolo
Journal:  Nat Chem Biol       Date:  2015-03-09       Impact factor: 15.040

3.  Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.

Authors:  Mafalda Concilli; Raffaella Petruzzelli; Silvia Parisi; Federico Catalano; Francesco Sirci; Francesco Napolitano; Mario Renda; Luis J V Galietta; Diego Di Bernardo; Roman S Polishchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-07       Impact factor: 12.779

4.  Novel factor in olfactory ensheathing cell-astrocyte crosstalk: Anti-inflammatory protein α-crystallin B.

Authors:  Aybike Saglam; Anne L Calof; Susan Wray
Journal:  Glia       Date:  2020-12-12       Impact factor: 8.073

5.  Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.

Authors:  Elena V Polishchuk; Mafalda Concilli; Simona Iacobacci; Giancarlo Chesi; Nunzia Pastore; Pasquale Piccolo; Simona Paladino; Daniela Baldantoni; Sven C D van IJzendoorn; Jefferson Chan; Christopher J Chang; Angela Amoresano; Francesca Pane; Piero Pucci; Antonietta Tarallo; Giancarlo Parenti; Nicola Brunetti-Pierri; Carmine Settembre; Andrea Ballabio; Roman S Polishchuk
Journal:  Dev Cell       Date:  2014-06-05       Impact factor: 12.270

6.  siRNA screen identifies QPCT as a druggable target for Huntington's disease.

Authors:  Michael Hannus; Birte Sönnichsen; Sara Imarisio; Angeleen Fleming; Maria Jimenez-Sanchez; Wun Lam; Alessia Tarditi; Fiona Menzies; Teresa Ed Dami; Catherine Xu; Eduardo Gonzalez-Couto; Giulia Lazzeroni; Freddy Heitz; Daniela Diamanti; Luisa Massai; Venkata P Satagopam; Guido Marconi; Chiara Caramelli; Arianna Nencini; Matteo Andreini; Gian Luca Sardone; Nicola P Caradonna; Valentina Porcari; Carla Scali; Reinhard Schneider; Giuseppe Pollio; Cahir J O'Kane; Andrea Caricasole; David C Rubinsztein
Journal:  Nat Chem Biol       Date:  2015-04-06       Impact factor: 15.040

7.  A disorder-to-order structural transition in the COOH-tail of Fz4 determines misfolding of the L501fsX533-Fz4 mutant.

Authors:  Valentina Lemma; Massimo D'Agostino; Maria Gabriella Caporaso; Massimo Mallardo; Giorgia Oliviero; Mariano Stornaiuolo; Stefano Bonatti
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.

Authors:  Giancarlo Chesi; Ramanath N Hegde; Simona Iacobacci; Mafalda Concilli; Seetharaman Parashuraman; Beatrice Paola Festa; Elena V Polishchuk; Giuseppe Di Tullio; Annamaria Carissimo; Sandro Montefusco; Diana Canetti; Maria Monti; Angela Amoresano; Piero Pucci; Bart van de Sluis; Svetlana Lutsenko; Alberto Luini; Roman S Polishchuk
Journal:  Hepatology       Date:  2016-01-25       Impact factor: 17.425

Review 9.  Wilson's disease: Prospective developments towards new therapies.

Authors:  Giusy Ranucci; Roman Polishchuck; Raffaele Iorio
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

10.  The engineered expression of secreted HSPB5-Fc in CHO cells exhibits cytoprotection in vitro.

Authors:  Jing Li; Jingjing Yu; Wenxian Xue; Huili Huang; Longjun Yan; Fan Sang; Shuangshuang An; Jing Zhang; Mingli Wang; Jun Zhang; Hui Li; Xiukun Cui; Jiang He; Yanzhong Hu
Journal:  BMC Biotechnol       Date:  2021-06-14       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.